The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B Cell tolerance by regulating substrate specificity

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2527-2535

  Zikherman, Julie ^a   Parameswaran, Ramya ^a   Hermiston, Michelle ^a   Weiss, Arthur ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD45 ANTIGEN; PROTEIN KINASE LCK; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE MUTATION; GENETIC SUSCEPTIBILITY; IMMUNOLOGICAL TOLERANCE; LUPUS LIKE SYNDROME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

ALLELES; ANIMALS; ANTIGENS, CD45; B-LYMPHOCYTE SUBSETS; GENETIC VARIATION; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PROTEIN STRUCTURE, TERTIARY; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES; SRC-FAMILY KINASES; SUBSTRATE SPECIFICITY;

EID: 84874859983     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202928     Document Type: Article

References (59)

1. Zikherman, J., and A. Weiss. 2009. Antigen receptor signaling in the rheumatic diseases. Arthritis Res. Ther. 11: 202
2. Zouali, M., and G. Sarmay. 2004. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment. Arthritis Rheum. 50: 2730-2741
3. Harley, J. B., M. E. Alarcón-Riquelme, L. A. Criswell, C. O. Jacob, R. P. Kimberly, K. L. Moser, B. P. Tsao, T. J. Vyse, C. D. Langefeld, S. K. Nath, et al International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN). 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40: 204-210
4. Abraham, R. T., and A.Weiss. 2004. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4: 301-308
5. Iwashima, M., B. A. Irving, N. S. van Oers, A. C. Chan, and A. Weiss. 1994. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263: 1136-1139
6. Kurosaki, T., H. Shinohara, and Y. Baba. 2010. B cell signaling and fate decision. Annu. Rev. Immunol. 28: 21-55
7. Gauld, S. B., and J. C. Cambier. 2004. Src-family kinases in B-cell development and signaling. Oncogene 23: 8001-8006
8. Xu, Y., K. W. Harder, N. D. Huntington, M. L. Hibbs, and D. M. Tarlinton. 2005. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22: 9-18
9. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311
10. Shultz, L. D., P. A. Schweitzer, T. V. Rajan, T. Yi, J. N. Ihle, R. J. Matthews, M. L. Thomas, and D. R. Beier. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73: 1445-1454
11. Tsui, H. W., K. A. Siminovitch, L. de Souza, and F. W. Tsui. 1993. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4: 124-129
12. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T.Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549-560
13. Maxwell, M. J., M. Duan, J. E. Armes, G. P. Anderson, D. M. Tarlinton, and M. L. Hibbs. 2011. Genetic segregation of inflammatory lung disease and autoimmune disease severity in SHIP-1-/- mice. J. Immunol. 186: 7164-7175
14. Yarkoni, Y., A. Getahun, and J. C. Cambier. 2010. Molecular underpinning of Bcell anergy. Immunol. Rev. 237: 249-263
15. Hermiston, M. L., J. Zikherman, and J. W. Zhu. 2009. CD45, CD148, and Lyp/ Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. Immunol. Rev. 228: 288-311
16. Rhee, I., and A. Veillette. 2012. Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat. Immunol. 13: 439-447
17. Stone, J. D., L. A. Conroy, K. F. Byth, R. A. Hederer, S. Howlett, Y. Takemoto, N. Holmes, and D. R. Alexander. 1997. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-zeta, and ZAP-70. J. Immunol. 158: 5773-5782
18. Byth, K. F., L. A. Conroy, S. Howlett, A. J. Smith, J. May, D. R. Alexander, and N. Holmes. 1996. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J. Exp. Med. 183: 1707-1718
19. Kishihara, K., J. Penninger, V. A. Wallace, T. M. Kündig, K. Kawai, A. Wakeham, E. Timms, K. Pfeffer, P. S. Ohashi, M. L. Thomas, et al. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45- exon6 protein tyrosine phosphatase-deficient mice. Cell 74: 143-156
20. Mee, P. J., M. Turner, M. A. Basson, P. S. Costello, R. Zamoyska, and V. L. Tybulewicz. 1999. Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice. Eur. J. Immunol. 29: 2923-2933
21. Zhu, J. W., T. Brdicka, T. R. Katsumoto, J. Lin, and A. Weiss. 2008. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity 28: 183-196
22. McNeill, L., R. L. Cassady, S. Sarkardei, J. C. Cooper, G. Morgan, and D. R. Alexander. 2004. CD45 isoforms in T cell signalling and development. Immunol. Lett. 92: 125-134
23. Tchilian, E. Z., and P. C. Beverley. 2006. Altered CD45 expression and disease. Trends Immunol. 27: 146-153
24. Dornan, S., Z. Sebestyen, J. Gamble, P. Nagy, A. Bodnar, L. Alldridge, S. Doe, N. Holmes, L. K. Goff, P. Beverley, et al. 2002. Differential association of CD45 isoforms withCD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. J. Biol. Chem. 277: 1912-1918
25. Xu, Z., and A. Weiss. 2002. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3: 764-771
26. Desai, D. M., J. Sap, J. Schlessinger, and A. Weiss. 1993. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase. Cell 73: 541-554
27. Majeti, R., A. M. Bilwes, J. P. Noel, T. Hunter, and A. Weiss. 1998. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279: 88-91
28. Majeti, R., Z. Xu, T. G. Parslow, J. L. Olson, D. I. Daikh, N. Killeen, and A. Weiss. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103: 1059-1070
29. Hermiston, M. L., A. L. Tan, V. A. Gupta, R. Majeti, and A. Weiss. 2005. The juxtamembrane wedge negatively regulates CD45 function in B cells. Immunity 23: 635-647
30. Hermiston, M. L., J. Zikherman, A. L. Tan, V. C. Lam, N. M. Cresalia, N. Oksenberg, N. Goren, D. Brassat, J. R. Oksenberg, and A. Weiss. 2009. Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses. Proc. Natl. Acad. Sci. USA 106: 546-551
31. Zikherman, J., K. Doan, R. Parameswaran, W. Raschke, and A. Weiss. 2012. Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival. Proc. Natl. Acad. Sci. USA 109: E3-E12
32. Zikherman, J., C. Jenne, S. Watson, K. Doan, W. Raschke, C. C. Goodnow, and A. Weiss. 2010. CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development. Immunity 32: 342-354
33. McNeill, L., R. J. Salmond, J. C. Cooper, C. K. Carret, R. L. Cassady-Cain, M. Roche-Molina, P. Tandon, N. Holmes, and D. R. Alexander. 2007. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses. Immunity 27: 425-437
34. Virts, E. L., O. Diago, and W. C. Raschke. 2003. A CD45 minigene restores regulated isoform expression and immune function in CD45-deficient mice: therapeutic implications for human CD45-null severe combined immunodeficiency. Blood 101: 849-855
35. Zikherman, J., M. Hermiston, D. Steiner, K. Hasegawa, A. Chan, and A. Weiss. 2009. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J. Immunol. 182: 4093-4106
36. Ashwell, J. D., and U. D'Oro. 1999. CD45 and Src-family kinases: and now for something completely different. Immunol. Today 20: 412-416
37. Palacios, E. H., and A. Weiss. 2004. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23: 7990-8000
38. Nika, K., C. Soldani, M. Salek, W. Paster, A. Gray, R. Etzensperger, L. Fugger, P. Polzella, V. Cerundolo, O. Dushek, et al. 2010. Constitutively active Lck kinase in T cells drives antigen receptor signal transduction. Immunity 32: 766-777
39. Becker, A. M., L. M. DeFord-Watts, C. Wuelfing, and N. S. van Oers. 2007. The constitutive tyrosine phosphorylation of CD3zeta results from TCR-MHC interactions that are independent of thymic selection. J. Immunol. 178: 4120-4128
40. van Oers, N. S., N. Killeen, and A. Weiss. 1996. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J. Exp. Med. 183: 1053-1062
41. Hibbs, M. L., K. W. Harder, J. Armes, N. Kountouri, C. Quilici, F. Casagranda, A. R. Dunn, and D. M. Tarlinton. 2002. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J. Exp. Med. 196: 1593-1604
42. Gross, A. J., J. R. Lyandres, A. K. Panigrahi, E. T. Prak, and A. L. DeFranco. 2009. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J. Immunol. 182: 5382-5392
43. Scapini, P., Y. Hu, C. L. Chu, T. S. Migone, A. L. Defranco, M. A. Cassatella, and C. A. Lowell. 2010. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J. Exp. Med. 207: 1757-1773
44. Gervais, F. G., and A. Veillette. 1995. The unique amino-terminal domain of p56lck regulates interactions with tyrosine protein phosphatases in T lymphocytes. Mol. Cell. Biol. 15: 2393-2401
45. Gervais, F. G., and A. Veillette. 1997. Reconstitution of interactions between protein-tyrosine phosphatase CD45 and tyrosine-protein kinase p56(lck) in nonlymphoid cells. J. Biol. Chem. 272: 12754-12761
46. Ng, D. H., J. D. Watts, R. Aebersold, and P. Johnson. 1996. Demonstration of a direct interaction between p56lck and the cytoplasmic domain of CD45 in vitro. J. Biol. Chem. 271: 1295-1300
47. Leitenberg, D., T. J. Novak, D. Farber, B. R. Smith, and K. Bottomly. 1996. The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J. Exp. Med. 183: 249-259
48. Veillette, A., M. A. Bookman, E. M. Horak, and J. B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosineprotein kinase p56lck. Cell 55: 301-308
49. Samelson, L. E., A. F. Phillips, E. T. Luong, and R. D. Klausner. 1990. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87: 4358-4362
50. Ley, S. C., M. Marsh, C. R. Bebbington, K. Proudfoot, and P. Jordan. 1994. Distinct intracellular localization of Lck and Fyn protein tyrosine kinases in human T lymphocytes. J. Cell Biol. 125: 639-649
51. O'Neill, S. K., A. Getahun, S. B. Gauld, K. T. Merrell, I. Tamir, M. J. Smith, J. M. Dal Porto, Q. Z. Li, and J. C. Cambier. 2011. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity 35: 746-756
52. Glynne, R., G. Ghandour, J. Rayner, D. H. Mack, and C. C. Goodnow. 2000. Blymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 176: 216-246
53. Flores-Borja, F., P. S. Kabouridis, E. C. Jury, D. A. Isenberg, and R. A. Mageed. 2005. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 52: 3955-3965
54. Huck, S., R. Le Corre, P. Youinou, and M. Zouali. 2001. Expression of B cell receptor-associated signalingmolecules in human lupus. Autoimmunity 33: 213-224
55. Liossis, S. N., E. E. Solomou, M. A. Dimopoulos, P. Panayiotidis, M. M. Mavrikakis, and P. P. Sfikakis. 2001. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J. Investig. Med. 49: 157-165
56. Lu, R., G. S. Vidal, J. A. Kelly, A. M. Delgado-Vega, X. K. Howard, S. R. Macwana, N. Dominguez, W. Klein, C. Burrell, I. T. Harley, et al BIOLUPUS and GENLES Multicenter Collaborations. 2009. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun. 10: 397-403
57. Jenks, S. A., and I. Sanz. 2009. Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun. Rev. 8: 209-213
58. Tsantikos, E., M. J. Maxwell, N. Kountouri, K. W. Harder, D. M. Tarlinton, and M. L. Hibbs. 2012. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development. J. Immunol. 189: 1726-1736
59. Cornall, R. J., J. G. Cyster, M. L. Hibbs, A. R. Dunn, K. L. Otipoby, E. A. Clark, and C. C. Goodnow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8: 497-508